Deconstructing the Treatment Effect of Remdesivir in the Adaptive Coronavirus Disease 2019 (COVID-19) Treatment Trial-1: Implications for Critical Care Resource Utilization-论文-万方医学网

Deconstructing the Treatment Effect of Remdesivir in the Adaptive Coronavirus Disease 2019 (COVID-19) Treatment Trial-1: Implications for Critical Care Resource Utilization

导出原文传递

翻译打印收藏纠错

作者： Fintzi, Jonathan ^[1] ; Bonnett, Tyler ^[2] ; Sweeney, Daniel A. ^[3] ; Huprikar, Nikhil A. ^[4] ; Ganesan, Anuradha ^[5] ; Frank, Maria G. ^[6] ; McLellan, Susan L. F. ^[7] ; Dodd, Lori E. ^[8] ; Tebas, Pablo ^[9] ; Mehta, Aneesh K.

作者单位： Biostat Res Branch,NIAID ^[1] Clin Monitoring Res Program Directorate,Frederick Natl Lab Canc Res ^[2] Dept Med,Univ Calif San Diego ^[3] Dept Med,Walter Reed Natl Mil Med Ctr ^[4] Walter Reed Natl Mil Med Ctr,Uniformed Serv Univ Hlth Sci ^[5] Sch Med,Univ Colorado ^[6] Div Infect Dis,Univ Texas Med Branch ^[7] Div Infect Dis,Univ Penn ^[8] Sch Med,Emory Univ ^[9]

关键词 clinical progression critical care multistate models respiratory therapies MODEL

发布时间 2022-12-22

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除